This inventor holds 5 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Innovations and Contributions of Anne-Christine Bay-Jensen
Introduction
Anne-Christine Bay-Jensen is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of pharmacogenetics, particularly in the treatment of cartilage disorders such as osteoarthritis. With a total of 5 patents to her name, her work focuses on developing biomarkers that enhance treatment strategies for patients.
Latest Patents
One of her latest patents is titled "Markers useful in enrichment strategies for the treatment of osteoarthritis." This invention relates to pharmacogenetics and involves biomarkers associated with the clinical response to treatment for cartilage disorders. It emphasizes the combination of JSW measurements and specific protein levels found in blood, serum, synovial fluid, or urine. These biomarkers can be utilized in clinical trials to enrich patient selection and adapt treatment strategies effectively.
Another notable patent is "Inflammatory biomarkers for predicting responsiveness to FGF-18 compound." This invention focuses on biomarkers that predict the clinical response to an FGF-18 compound before or during treatment. It highlights the use of specific proteins present in bodily fluids to diagnose and tailor treatment for cartilage disorders. This innovation aims to improve patient outcomes by identifying suitable candidates for treatment based on their biomarker profiles.
Career Highlights
Anne-Christine Bay-Jensen is currently associated with Merck Patent GmbH, where she continues to advance her research and innovations. Her work has been instrumental in bridging the gap between pharmacogenetics and clinical applications, making her a valuable asset in the field of medical research.
Collaborations
She has collaborated with notable colleagues such as Hans Guehring and Per Qvist, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Anne-Christine Bay-Jensen's contributions to pharmacogenetics and her innovative patents are paving the way for improved treatment strategies for cartilage disorders. Her work exemplifies the impact of research and innovation in enhancing patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile